Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid MalignanciesCombination Therapy with ATRA-TCP in AML and…

Overview of attention for article published in Clinical Cancer Research, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 23,669 followers.

RRIDs were included in the Clinical Cancer Research paper "Clinical responsiveness to All-trans Retinoic Acid…" (https://t.co/BAYY7idNoM). Thank you for making your #methodsmatter. #ReproducibleResearch

Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies https://t.co/dq6AUnNh8J

Wonderful paper from @tayari_m , Helena Gomes Dos Santos, Justin Watts and many others @SylvesterCancer exploring ATRA + LSD1 inhibition in #AML and #MDS!

RT @CCR_AACR: Clinical trial by Tayari et al shows that LSD1 inhibition sensitizes acute #MyeloidLeukemia cells to all-trans retinoic acid/…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.